Breast angiosarcoma is an extremely rare cancer that starts in the blood or lymph vessels within the breast tissue. This disease presents unique challenges because it’s so uncommon—only about one in a million people receive an angiosarcoma diagnosis each year in the United States—and it can develop either spontaneously or as a result of previous cancer treatment.

Understanding Breast Angiosarcoma

Breast angiosarcoma represents a very small fraction of all breast cancers. When we talk about how rare this disease truly is, we’re discussing a cancer that accounts for less than 0.04% of malignant breast tumors. Despite its rarity, understanding this condition is crucial for anyone who has received breast cancer treatment in the past or who notices unusual changes in their breast tissue.^[1][2]

This cancer develops when cells lining blood vessels or lymphatic vessels (the thin tubes that carry fluid throughout the body’s immune system) begin to grow abnormally and uncontrollably. Unlike normal cells that die when they should, these cancerous cells continue multiplying and can form tumors. Because blood and lymph vessels exist throughout the body, angiosarcoma can technically develop anywhere, though the breast is one of the more common locations.^[1]

Two Distinct Forms of the Disease

Breast angiosarcoma appears in two main forms, and understanding the difference between them is important because they affect different age groups and have different underlying causes.

Primary breast angiosarcoma occurs in people who have never had breast cancer before. This form typically affects younger women, most commonly those in their 30s and 40s. The causes behind primary breast angiosarcoma remain somewhat mysterious to researchers, mainly because the disease is so rare that studying it in depth has been challenging. Unlike many cancers, primary breast angiosarcoma doesn’t seem to follow predictable patterns, and doctors don’t yet fully understand what triggers the cells to become cancerous.^[1][2]

Secondary breast angiosarcoma (also called treatment-related or radiation-induced angiosarcoma) develops in people who have previously been treated for breast cancer. This form is much better understood than the primary type. It typically appears in older women, with a median age between 67 and 71 years, and usually develops seven to ten years after radiation therapy for breast cancer. According to a 2019 report, approximately one in 1,000 people who received radiation for breast cancer eventually developed angiosarcoma in the breast or chest wall.^[1][2]

Epidemiology: Who Gets This Disease

The overall incidence of angiosarcoma across all body sites is extremely low. For every one million people in the United States, only one person will be diagnosed with angiosarcoma in any given year. When we narrow this down to just breast angiosarcoma, the numbers become even smaller, representing only about 0.1% to 0.2% of all breast cancer cases.^[1][7]

The disease shows interesting patterns when we look at different patient groups. Primary angiosarcoma tends to affect women in their reproductive years and early middle age, while secondary angiosarcoma appears in an older population who have survived an earlier breast cancer. Both men and women can develop breast angiosarcoma, though it’s more commonly seen in women, likely because women undergo breast cancer treatment more frequently than men.^[2][7]

Geographic and racial patterns haven’t been clearly established, partly because the disease is so rare that gathering enough data to identify such patterns has proven difficult. What researchers do know is that the incidence of secondary angiosarcoma may be increasing slightly as more people survive breast cancer and live long enough to potentially develop this late complication of radiation treatment.^[2]

Causes: What Triggers This Cancer

The exact biological mechanism that transforms normal blood vessel cells into cancerous ones remains incompletely understood. However, researchers have identified several factors that appear to play a role in the development of breast angiosarcoma.

For secondary angiosarcoma, radiation exposure is the most clearly established cause. When breast tissue receives radiation therapy—typically used after lumpectomy or mastectomy to kill any remaining cancer cells—the radiation can damage the DNA in healthy cells. While higher radiation doses (above 50 Gray) tend to cause cells to die, lower doses may cause DNA damage and instability without killing the cells. This unstable DNA can eventually lead to cancerous changes. Interestingly, angiosarcomas often develop at the edge of radiation fields, where the dose and its effects on tissue may be uneven.^[2]

The development of secondary angiosarcoma doesn’t happen immediately after radiation. Instead, there’s typically a latency period—a stretch of time between the radiation treatment and the appearance of the cancer. Multiple studies have shown this latency period ranging from five to ten years, with a median around 10.5 years. This long delay means that breast cancer survivors need to remain vigilant about breast health for many years after completing treatment.^[2][8]

Chronic lymphedema (persistent swelling caused by lymph fluid buildup) has also been linked to breast angiosarcoma. When lymph nodes are removed during breast cancer surgery, or when radiation damages lymphatic vessels, fluid can accumulate in the breast or arm. This chronic swelling creates an environment that may promote the development of angiosarcoma, though researchers are still working to understand exactly how this happens.^[1][2]

For primary angiosarcoma, the causes remain largely unknown. Some research suggests that exposure to certain chemicals—such as vinyl chloride, arsenic, or thorium dioxide—might increase risk, though this connection is more clearly established for angiosarcomas in other parts of the body, particularly the liver. Genetic factors may also play a role, but family history of breast cancer doesn’t appear to be a strong predictor of angiosarcoma specifically.^[7][11]

Risk Factors: Who Faces Higher Chances

Several factors can increase a person’s likelihood of developing breast angiosarcoma, though it’s important to remember that having risk factors doesn’t guarantee someone will develop the disease, and people without any known risk factors can still be affected.

Previous radiation therapy to the breast or chest wall stands out as the most significant risk factor for secondary angiosarcoma. The risk appears to be dose-dependent—meaning that higher radiation doses and repeated treatments increase the likelihood of eventually developing angiosarcoma. People who received radiation for childhood cancers, such as Hodgkin lymphoma, may face particularly high risk if the radiation field included the chest area.^[2][7]

Surgical removal of lymph nodes, a common procedure during breast cancer treatment, creates risk through the chronic lymphedema it can cause. When lymphatic drainage is compromised, the resulting swelling and fluid accumulation may set the stage for angiosarcoma development years down the line.^[1][7]

Age plays a complex role in risk. For primary angiosarcoma, being between 30 and 50 years old appears to be the highest-risk period. For secondary angiosarcoma, risk increases with age, partly because older individuals are more likely to have survived breast cancer and received radiation treatment years earlier. The general aging process may also make cells more vulnerable to cancerous changes.^[2]

Environmental and occupational exposures to certain chemicals have been associated with increased angiosarcoma risk, though this connection is stronger for angiosarcomas in organs like the liver than for breast angiosarcoma specifically. People who worked with vinyl chloride in manufacturing, or who were exposed to arsenic or thorium dioxide, may face elevated risk.^[7][11]

Some chronic inflammatory conditions affecting the breast may also increase risk, though this is less clearly established than other risk factors. The ongoing inflammation and tissue damage that characterize these conditions might create an environment conducive to cancerous changes in blood vessel cells.^[7]

Recognizing the Symptoms

The symptoms of breast angiosarcoma can vary significantly depending on whether it’s a primary or secondary form, and unfortunately, these symptoms often look similar to other, more common breast conditions. This similarity contributes to delays in diagnosis, which is why understanding the specific characteristics of angiosarcoma symptoms is so important.

For primary breast angiosarcoma, the most common presentation is a lump or mass in the breast. This lump may feel firm or “squishy” to the touch, and one of its most distinctive characteristics is how quickly it grows. Unlike many benign breast lumps that remain stable in size, an angiosarcoma mass tends to enlarge rapidly, sometimes over just a few weeks or months. The skin over the mass may appear thickened, and there might be a discolored area that looks like a rash or bruise—often with purple, red, or blue tones—that doesn’t fade as a normal bruise would.^[1][2]

Secondary angiosarcoma often presents differently, and this difference can lead to misdiagnosis. Rather than a deep mass in the breast tissue, secondary angiosarcoma frequently appears as a skin change. It might look like a small skin tag, a pimple that won’t heal, or a lesion with an unusual purple or blue hue. Some people notice what appears to be a rash that spreads over time, or an area of skin that looks bruised even though there was no injury. Because these changes look like skin conditions rather than breast cancer, many patients initially consult a dermatologist rather than a breast specialist, which can delay proper diagnosis.^[1][9]

Both forms of angiosarcoma can cause swelling in the breast or arm, particularly if the cancer is affecting lymphatic vessels or if it’s developing in an area already affected by lymphedema. Some people experience pain in the affected area, though angiosarcoma can also be painless, which sometimes leads people to dismiss it as unimportant.^[1][7]

Less common symptoms might include bleeding from a breast lesion, general fatigue that doesn’t improve with rest, or unexplained weight loss. These systemic symptoms typically appear only when the cancer has grown larger or has begun to spread to other parts of the body.^[7]

One particularly important point about angiosarcoma symptoms is that they can be subtle at first and easily overlooked. A small discolored patch of skin or a slowly enlarging lump might not seem alarming initially. However, any persistent change in the breast—especially in someone who has previously received radiation therapy—deserves medical attention. The key warning signs are changes that don’t resolve on their own within a few weeks, areas that continue to grow or spread, and any bruise-like discoloration that appeared without an injury.^[1][9]

Prevention Strategies

Given the rarity of breast angiosarcoma and the incomplete understanding of what causes primary angiosarcoma, specific prevention strategies are limited. However, there are several approaches that can help reduce risk, particularly for secondary angiosarcoma.

For people undergoing radiation therapy for breast cancer, modern radiation techniques have been developed to minimize the risk of secondary cancers. Radiation oncologists now use more precise targeting methods that focus the radiation beam more accurately on the tumor area while sparing surrounding healthy tissue. These techniques, including three-dimensional conformal radiation therapy and intensity-modulated radiation therapy, may help reduce the long-term risk of developing angiosarcoma, though it’s important to note that the benefits of radiation in treating the original breast cancer far outweigh the small risk of eventually developing angiosarcoma.^[2]

Managing lymphedema effectively represents another preventive approach. For people who have had lymph nodes removed or who have received radiation that damaged lymphatic vessels, taking steps to minimize lymphedema can potentially reduce angiosarcoma risk. This includes protecting the affected arm from injuries, infections, and excessive heat; wearing compression garments as recommended; performing prescribed exercises; and maintaining a healthy body weight. While these measures haven’t been proven to prevent angiosarcoma specifically, they do help control lymphedema, which is a known risk factor.^[1][2]

Avoiding exposure to known chemical risk factors—such as vinyl chloride, arsenic, and thorium dioxide—can help reduce overall angiosarcoma risk, though workplace safety regulations in most developed countries have significantly limited exposure to these substances. People who work in industries where such exposure is possible should follow all safety protocols and use protective equipment.^[7][11]

Perhaps the most important “prevention” strategy is actually early detection through vigilant monitoring. Breast cancer survivors who received radiation therapy should remain alert to any changes in their treated breast for the rest of their lives. Regular self-examination, clinical breast exams, and appropriate imaging help catch angiosarcoma at earlier, more treatable stages. Medical professionals recommend that anyone who has received breast radiation should immediately report any new lumps, persistent skin changes, or areas of discoloration to their doctor rather than waiting to see if they resolve on their own.^[1][8]

For people in the high-risk period (seven to ten years after radiation therapy), some specialists recommend enhanced surveillance, though there’s no universal agreement on what this should include beyond regular clinical exams. Some doctors suggest more frequent imaging, while others rely primarily on careful physical examination and prompt investigation of any concerning changes.^[2]

How the Body Changes: Pathophysiology

Understanding what happens inside the body when breast angiosarcoma develops helps explain why this cancer behaves the way it does and why it can be so challenging to treat.

At the cellular level, angiosarcoma begins when the endothelial cells (the cells that form the inner lining of blood and lymph vessels) undergo abnormal changes in their DNA. Unlike normal endothelial cells, which have a regulated life cycle—growing when needed and dying when they should—these altered cells lose their normal growth controls. They begin multiplying rapidly and continuously, refusing to die even when they should.^[11]

As these abnormal cells proliferate, they form tumors that maintain characteristics of blood vessel tissue. Under a microscope, pathologists can see that the tumor cells are trying to form blood vessel-like structures, though these structures are disorganized and dysfunctional. The tumors are highly vascular (full of blood vessels), which gives them their characteristic appearance on imaging and explains why they may bleed easily.^[2]

One of the most concerning aspects of angiosarcoma’s pathophysiology is its aggressive growth pattern. The cancer doesn’t grow as a neat, contained mass with clear borders. Instead, it tends to infiltrate and invade surrounding breast tissue in an irregular, spreading pattern. This infiltrative growth makes it difficult to determine exactly where the tumor ends and normal tissue begins, which creates challenges during surgery—surgeons can’t always see or feel the full extent of the cancer, making it hard to remove all of it.^[2][11]

The cancer cells also have a strong tendency to spread beyond their original location. They can travel through the bloodstream or lymphatic system to distant parts of the body, establishing new tumors in organs like the lungs, liver, or bones. This process, called metastasis, often happens even when the original tumor in the breast appears relatively small. The lungs are the most common site for angiosarcoma metastasis, which can cause breathing problems and other complications.^[2][11]

In secondary angiosarcoma that develops after radiation, the pathophysiology involves the long-term effects of radiation on tissue. The radiation causes ongoing DNA damage and creates an environment of chronic inflammation and abnormal tissue repair. Over years, these conditions can cause endothelial cells to accumulate enough genetic mutations to become cancerous. The fact that secondary angiosarcomas often develop at the edges of radiation fields suggests that sublethal radiation doses—enough to damage cells but not kill them—may be particularly dangerous in the long term.^[2]

The tumors are typically graded based on how abnormal the cells look under a microscope and how quickly they’re dividing. High-grade angiosarcomas have cells that look very different from normal cells and are dividing rapidly, which correlates with more aggressive behavior and poorer outcomes. Low-grade angiosarcomas more closely resemble normal blood vessel tissue and tend to grow more slowly, though even low-grade angiosarcomas are considered aggressive compared to most other cancer types.^[7]

At the molecular level, researchers have identified certain genetic changes common in angiosarcomas, including amplifications of genes involved in blood vessel growth and mutations affecting cell cycle control. Understanding these molecular changes is helping scientists develop targeted treatments, though much work remains to be done in this area.^[11]

The tumors also affect the normal function of blood and lymph vessels in the breast. As the cancer grows, it can block or damage these vessels, leading to swelling, fluid accumulation, and impaired circulation in the affected breast or arm. This dysfunction contributes to some of the symptoms people experience and can complicate treatment.^[2]

Another important aspect of angiosarcoma’s pathophysiology is its high rate of local recurrence. Even after surgery removes all visible and detectable tumor tissue, the cancer frequently returns in the same area. This happens because of those microscopic extensions of cancer that spread beyond the visible tumor margins, and because the underlying conditions that allowed the cancer to develop in the first place—such as radiation-damaged tissue or chronic lymphedema—remain present after the tumor is removed.^[2][8]